Trial Information

Summary: Volunteers Needed for Atrial Fibrillation Study

Dr. Khaled Ziada, of the University of Kentucky Gill Heart Institute, is conducting a research study to demonstrate the effi cacy of a study drug compared to Warfarin (Coumadin) for the prevention of strokes in patients with non-valvular atrial fibrillation.

You may qualify for this study if you had a stroke in the past year or if you have three of the following:

• hypertension
• over age 75
• diabetes
• heart failure

If you qualify, you will be compensated for your participation. The study drug will be provided free of charge. In addition, your willingness to take part in this study may result in the possibility of discontinuing Warfarin (Coumadin) therapy. For further information, please contact the study coordinator, at (859) 323-8663.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:45:25 AM